Test_pellets

Pellets – an oral dosage form to improve patient compliance

Our Vismon® coating technology stimulates salivation and creates a pleasant tasting, soft pellet pulp in the mouth that is easy to swallow.

Pellets are small, rounded, spherical nuclei with an average diameter of 0.1 to 3 mm. The surface of pellets is typically smooth and not very porous.

Pellets can be formulated as immediate release or sustained release dosage forms and can also be coated to deliver drugs to specific sites in the gastrointestinal tract. Due to their free-flowing properties, pellets offer a high degree of flexibility in formulation development.

pellets by losan pharma
stick pack pellets
pellets losan pharma

Pelletisation can be achieved by layering the drug onto the starter pellet or by ring die extrusion and spheronisation:

Drug layering

Drug layering is similar to a film coating process. One or more active ingredients are applied in layers as a solution or suspension onto starter pellets (e.g. sugar starch, MCC or tartaric acid spheres with a size range of 0.1 to 2 mm).

Extruded pellets

Extruded pellets are produced by a granulation process in which a powder mixture of API and excipients is agglomerated using a binding liquid. The material is then processed in a ring die extruder to produce high density extrudates. These extrudates are then formed into small rounded or spherical pellets.

dual release pellet

Recent Project at Losan: Dual Release Pellets

Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext Erklärungstext 

technologies

Pharmaceutical pellets services

Pellets by extrusion/spheronisation or using starter pellets

Transfer trials

Scale-up from pilot to commercial scale

GMP manufacturing: Production of clinical trial supplies, release of study medication (?) and stability studies

Extensive dosage form capabilities:

  • Customised release by fluid bed coating (targeted release, extended release)
  • Matrix formulations by double chamber filling of immediate and extended release pellets
  • Capsules and stick packs

Advantages of our Pellets

The main advantages for the development and use of pharmaceutical pellets are:

R

Preparation of modified release multiple dosage forms with different drug release patterns

R

Taste masking of bitter tasting drugs

R

Easy to swallow thanks to our Vismon® coating technology

R

Polymer-based pellets for controlled drug release patterns

R

Increased mechanical strength of the dosage form

R

Flexibility in dosage form design and development

R

Can be used to combine incompatible drugs

R

Avoid high local concentrations as they disperse freely in the GI tract

R

Minimise potential side effects without decreasing bioavailability

R

Compared to monolithic forms, multiparticulate distribution of particles in the GI tract reduces fluctuations in plasma levels